JAK2 and pulmonary arterial hypertension: The latter conclusion is supported by the lack of reported association between development of pulmonary hypertension and the allelic burden of common Janus kinase 2 (JAK2) allelic variant (V617F), which is responsible for many myeloproliferative neoplasms [38,39].